当前位置:首页 - 行情中心 - 兴齐眼药(300573) - 财务分析 - 现金流量表

兴齐眼药

(300573)

  

流通市值:136.85亿  总市值:178.17亿
流通股本:1.88亿   总股本:2.45亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,140,671,875.59531,751,958.341,879,008,345.81,422,273,906.89
  收到其他与经营活动有关的现金15,100,925.1113,293,678.2819,698,104.2117,510,188.84
  经营活动现金流入小计1,155,772,800.7545,045,636.621,898,706,450.011,439,784,095.73
  购买商品、接受劳务支付的现金89,201,779.4328,549,744.93146,862,617.13126,276,463.73
  支付给职工以及为职工支付的现金305,850,969.36163,577,708.14558,026,438.19406,418,410.76
  支付的各项税费166,090,711.8968,370,912.72215,147,348.73153,661,252.86
  支付其他与经营活动有关的现金289,079,458.4493,925,340.95561,687,082.78397,762,192.46
  经营活动现金流出小计850,222,919.12354,423,706.741,481,723,486.831,084,118,319.81
  经营活动产生的现金流量净额305,549,881.58190,621,929.88416,982,963.18355,665,775.92
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额44,247.79-326,00070,860.56
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计44,247.79-326,00070,860.56
  购建固定资产、无形资产和其他长期资产支付的现金88,822,269.8733,351,433.77198,710,063.3104,208,978.61
  投资支付的现金--10,000,00010,000,000
  支付其他与投资活动有关的现金--7,284,068.52-
  投资活动现金流出小计88,822,269.8733,351,433.77215,994,131.82114,208,978.61
  投资活动产生的现金流量净额-88,778,022.08-33,351,433.77-215,668,131.82-114,138,118.05
三、筹资活动产生的现金流量:
  吸收投资收到的现金--22,167,470.64-
  取得借款收到的现金150,000,00080,000,000310,000,000230,000,000
  收到其他与筹资活动有关的现金28,743,814.18909,197.64,867,351.754,207,278.57
  筹资活动现金流入小计178,743,814.1880,909,197.6337,034,822.39234,207,278.57
  偿还债务支付的现金180,000,000100,000,000180,000,00070,000,000
  分配股利、利润或偿付利息支付的现金178,095,818.761,518,937.2466,573,730.15377,715,578.59
  支付其他与筹资活动有关的现金26,617,003.361,545,213.829,247,386.475,090,286.22
  筹资活动现金流出小计384,712,822.12103,064,151.02655,821,116.62452,805,864.81
  筹资活动产生的现金流量净额-205,969,007.94-22,154,953.42-318,786,294.23-218,598,586.24
四、汇率变动对现金及现金等价物的影响-1,624,291.66-78,921.6-109,296.21-38,697.9
五、现金及现金等价物净增加额9,178,559.9135,036,621.09-117,580,759.0822,890,373.73
  加:期初现金及现金等价物余额362,837,182.96362,837,182.96480,417,942.04480,417,942.04
  期末现金及现金等价物余额372,015,742.86497,873,804.05362,837,182.96503,308,315.77
补充资料:
  净利润334,826,054.8-338,061,776.59-
  资产减值准备8,790,633.82-8,036,272.7-
  固定资产和投资性房地产折旧41,930,834.96-84,413,365.38-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧41,930,834.96-84,413,365.38-
  无形资产摊销5,355,829.66-9,586,503.23-
  长期待摊费用摊销1,320,827.91-4,000,638.05-
  处置固定资产、无形资产和其他长期资产的损失-74,796.81-978,359.46-
  固定资产报废损失--14,050,574.47-
  财务费用4,427,696.75-5,822,076.18-
  递延所得税474,376.36-1,841,875.6-
  其中:递延所得税资产减少474,376.36-1,841,875.6-
  存货的减少-30,519,985.24--20,990,416.43-
  经营性应收项目的减少-74,486,798.66--144,415,694.62-
  经营性应付项目的增加4,586,582.83-95,544,245.63-
  其他4,198,975.22-11,551,965.9-
  现金的期末余额372,015,742.86-362,837,182.96-
  减:现金的期初余额362,837,182.96-480,417,942.04-
  现金及现金等价物的净增加额9,178,559.9--117,580,759.08-
公告日期2025-08-282025-04-292025-04-222024-10-29
审计意见(境内)标准无保留意见
TOP↑